SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 32 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,987 | -30.4% | 57,309 | +5.7% | 0.00% | – |
| Q2 2023 | $61,799 | +58756.2% | 54,210 | -22.8% | 0.00% | – |
| Q1 2023 | $105 | +5.0% | 70,191 | +4.4% | 0.00% | – |
| Q4 2022 | $100 | -99.9% | 67,242 | -15.0% | 0.00% | – |
| Q3 2022 | $123,000 | -59.5% | 79,081 | -40.9% | 0.00% | – |
| Q2 2022 | $304,000 | +164.3% | 133,705 | +168.8% | 0.00% | – |
| Q1 2022 | $115,000 | -77.3% | 49,744 | -43.0% | 0.00% | – |
| Q4 2021 | $506,000 | -81.4% | 87,290 | -66.3% | 0.00% | -100.0% |
| Q3 2021 | $2,721,000 | – | 258,659 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newtyn Management, LLC | 1,540,920 | $2,311,380 | 0.45% |
| Deuterium Capital Management, LLC | 11,000 | $16,500 | 0.03% |
| Duquesne Family Office | 100,000 | $150 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 112,900 | $169,350 | 0.00% |
| LEO BROKERAGE, LLC | 14,845 | $22,268 | 0.00% |
| Ergoteles LLC | 15,521 | $23,282 | 0.00% |
| UBS Group AG | 3,440 | $5,160 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 15,276 | $22,914 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 11,570 | $17,355 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 89,986 | $134,979 | 0.00% |